Welcome to our dedicated page for Gentex SEC filings (Ticker: GNTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gentex Corporation’s disclosures tell the story behind every auto-dimming mirror and digital vision system you see on the road. Whether you’re monitoring new OEM supply agreements or the cost of Gentex’s electrochromic glass expansion, the details hide inside 200-page forms. Our platform surfaces them quickly, turning the dense Gentex annual report 10-K simplified into clear narratives about segment revenue, ADAS content per vehicle, and R&D intensity.
Need to track executive moves? The moment a director buys shares, the Gentex Form 4 insider transactions real-time alert appears on this page. Curious about quarterly performance? Dive into the Gentex quarterly earnings report 10-Q filing; our AI extracts gross-margin swings and inventory trends, providing concise Gentex earnings report filing analysis. Material supply-chain announcements are flagged inside the Gentex 8-K material events explained feed, so you can react before the market digests the news.
What makes this page different? Stock Titan’s AI-powered summaries translate accounting jargon into plain language, perfect for understanding Gentex SEC documents with AI. You’ll find every document—proxy materials outlining Gentex proxy statement executive compensation, shelf registrations, and comment-letter correspondence—updated the instant EDGAR posts. Practical use cases include comparing mirror-segment profit in successive 10-Qs, spotting trends in Gentex executive stock transactions Form 4, and reviewing risk-factor shifts on supply shortages. If you’ve ever typed “Gentex SEC filings explained simply” into a search bar, the answer is right here.
Kevin C. Nash, Chief Financial Officer and Director of Gentex Corporation (GNTX), reported a transaction dated 08/26/2025 affecting his holdings. The filing shows 865 shares disposed of Common Stock at a price of $28.28 per share. After the reported transaction, Mr. Nash beneficially owned 54,304 shares directly. The form includes an explanatory note stating the shares were purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan. The Form 4 was signed on behalf of Mr. Nash by a power of attorney on 08/27/2025. No derivative securities or additional transactions are reported in this filing.
Gentex reported consolidated net sales of $657.9 million for the quarter ended June 30, 2025, up 15% from $572.9 million a year earlier, driven largely by the April 1, 2025 acquisition of VOXX which contributed $78.8 million of revenue. Consolidated gross profit rose to $225.3 million, and consolidated income from operations was $118.5 million. Net income attributable to Gentex was $96.0 million (diluted EPS $0.43), versus $86.0 million (EPS $0.37) in the comparable quarter.
Cash and cash equivalents decreased to $119.8 million from $233.3 million at year-end 2024 after investing activity, acquisition payments and share repurchases. Operating cash flow provided $314.6 million in the six months ended June 30, 2025. The company completed the VOXX acquisition for approximately $148.3 million in cash (total consideration, net $187.7 million including fair value of prior holdings) and made other biometric-related acquisitions; integration costs, severance and a $6.2 million impairment were recorded in the quarter.
FAQ
What is the current stock price of Gentex (GNTX)?
What is the market cap of Gentex (GNTX)?
